IMMUNOTHERAPY AFTER AUTOLOGOUS OR ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA, A SINGLE CENTER EXPERIENCE
PEDIATRIC BLOOD & CANCER(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
PEDIATRIC BLOOD & CANCER(2022)